Caladrius Biosciences Announces NIH Grant to Fund Retinal Disease Research
July 23, 2015 at 07:42 AM EDT
Caladrius Biosciences, Inc. ("Caladrius") (NASDAQ: CLBS), a cell therapy leader with a Phase 3 clinical program in immuno-oncology and ...